Strategic Acquisitions PCM Trials has recently acquired EmVenio Research and Clinical Trial Service B.V, expanding its geographic reach and service offerings in decentralized and hybrid clinical trials, presenting opportunities to target clients seeking comprehensive, patient-centric trial solutions across multiple regions.

Innovative Clinical Model The company's focus on developing the most patient-centric hybrid clinical trial models positions it as a preferred partner for organizations aiming to enhance patient engagement and retention, creating opportunities to upsell services tailored to innovative trial designs.

Global Expansion With a recently opened London office and its established presence in the US and Europe, PCM Trials is well-positioned to serve international clients and expand into new markets, making it attractive to global pharmaceutical and biotech companies seeking decentralized trial solutions.

Technological Stack Utilizing modern tools such as Sage Intacct, Office 365, and Java, PCM Trials demonstrates its commitment to leveraging technology for efficient trial management, offering opportunities to collaborate with organizations looking to modernize their research infrastructures.

Awards and Recognition Receiving the 2023 CSO50 Award highlights PCM Trials’ industry credibility and innovative approach, which can be leveraged in sales pitches to build trust and demonstrate the company's leadership in patient-centric decentralized research solutions.